About A4PBio
A4PBio is a company based in Sandwich (United Kingdom) founded in 2011 by Ian James, Carl Watson, and Scott Vincent was acquired by LabConnect in April 2024. The company has 34 employees as of December 31, 2024. A4PBio offers products and services including Bioanalytical Services, Biosample Operations, Logistics Services, Biomarker Strategy, and Laboratory Evaluations. A4PBio operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others.
- Headquarter Sandwich, United Kingdom
- Employees 34 as on 31 Dec, 2024
- Founders Ian James, Carl Watson, Scott Vincent
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
$2.18 M (USD)-8as on Mar 31, 2023
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
34
as on Dec 31, 2024
-
Acquired by
LabConnect
(Apr 22, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of A4PBio
A4PBio offers a comprehensive portfolio of products and services, including Bioanalytical Services, Biosample Operations, Logistics Services, Biomarker Strategy, and Laboratory Evaluations.
Provides project management for bioanalytical processes in clinical research
Manages operations for biosample handling and analysis in trials
Handles scientific material transport and storage securely
Offers consultancy on biomarker development for drug programs
Conducts evaluations and selections of laboratories for trials
Funding Insights of A4PBio
Detailed funding history for A4PBio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in A4PBio
A4PBio has secured backing from 1 investor. Prominent investors backing the company include LabConnect.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Laboratory testing, clinical trial research, and biopharma services are provided.
|
Locked | Locked | Locked |
Investor details for A4PBio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by A4PBio
Investment portfolio details for A4PBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - A4PBio
Detailed financials for A4PBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
A4pbio Comparisons
Peer comparison for A4PBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of A4PBio
A4PBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
Detailed competitors of A4PBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on A4pbio
Complete news archive for A4PBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about A4PBio
A4PBio was founded in 2011.
A4PBio is headquartered in Sandwich, United Kingdom.
As of Dec 31, 2024, the latest employee count at A4PBio is 34.
A4PBio is a scientific consultancy company specializing in bioanalytical services and bio-logistics solutions. They offer CRO oversight, project management, and consultancy services for regulatory compliant bioanalysis.
A4PBio's top competitors include Indegene, Zuellig Pharma and IntegriChain.
A4PBio offers Bioanalytical Services, Biosample Operations, Logistics Services, Biomarker Strategy, and Laboratory Evaluations.
A4PBio has 1 investor. Key investors include LabConnect.